logo

location icon
collection

Home Collection

040-4444-2424

Home > Find A Test Details

IRMA(IMATINIB RESISTANCE MUTATION ANALYSIS)IN CML

This test is useful for detecting over 90 known and novel mutations in ABL kinase domain of Ph chromosome including T3151 and P-loop mutations responsible for resistance to Imatinib in CML patients. Imatinib is a Tyrosine kinase inhibitor (TKI) which helps in overcoming mutations to aid in the treatment of CML.


How to prepare for the test?

Submit latest BCR-ABL Quantitative report along with sample.

Partner with us

Partnering with us offers entrepreneurs valuable mentoring, marketing guidance, and administrative support, paving the way for success.

For bulk test bookings, Reach out to us at:

[email protected]

Move To Top

Copyright © 2024 Apollo Diagnostics (Apollo Health and Lifestyle Limited), All Rights Reserved